Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production

Molecular and Cellular Biology

Volumn 33, Issue 14, 2013, Pages 2787-2796

  Sassa, Takayuki ^a   Ohno, Yusuke ^a   Kashiwagi, Toshiki ^a   Hirayama, Taisuke ^a   Kihara, Akio ^a   Suzuki, Shotaro ^b,c   Nomura, Toshifumi ^b   Shimizu, Hiroshi ^b   Nishioka, Chieko ^d   Itohara, Shigeyoshi ^d   Akiyama, Masashi ^e   Taguchi, Ryo ^f  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Albion Co Ltd   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f CHUBU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; CERAMIDE; SKIN LIPID; SPHINGOMYELIN; VERY LONG CHAIN FATTY ACID;

ARTICLE; CONTROLLED STUDY; ELOVL 1 GENE; EPIDERMIS; GENE; IN VITRO STUDY; LAMELLAR BODY; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; SKIN SURFACE; STRATUM CORNEUM;

ACETYLTRANSFERASES; ANIMALS; CERAMIDES; CYTOPLASMIC GRANULES; EPIDERMIS; FATTY ACIDS; FEMALE; GENES, LETHAL; HEK293 CELLS; HUMANS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERMEABILITY; SPHINGOSINE N-ACYLTRANSFERASE;

EID: 84880660131     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00192-13     Document Type: Article

References (30)

1. Proksch E, Brandner JM, Jensen JM. 2008. The skin: an indispensable barrier. Exp. Dermatol. 17:1063-1072.
2. Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y. 2009. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 91: 784-790.
3. Uchida Y, Holleran WM. 2008. Omega-O-acylceramide, a lipid essential for mammalian survival. J. Dermatol. Sci. 51:77-87.
4. Kihara A, Mitsutake S, Mizutani Y, Igarashi Y. 2007. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Prog. Lipid Res. 46:126-144.
5. Aldahmesh MA, Mohamed JY, Alkuraya HS, Verma IC, Puri RD, Alaiya AA, Rizzo WB, Alkuraya FS. 2011. Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. Am. J. Hum. Genet. 89:745-750.
6. Cameron DJ, Tong Z, Yang Z, Kaminoh J, Kamiyah S, Chen H, Zeng J, Chen Y, Luo L, Zhang K. 2007. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int. J. Biol. Sci. 3:111-119.
7. Eckl KM, Tidhar R, Thiele H, Oji V, Hausser I, Brodesser S, Preil ML, Onal-Akan A, Stock F, Muller D, Becker K, Casper R, Nurnberg G, Altmuller J, Nurnberg P, Traupe H, Futerman AH, Hennies HC. Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J. Invest. Dermatol., in press.
8. Jennemann R, Rabionet M, Gorgas K, Epstein S, Dalpke A, Rothermel U, Bayerle A, van der Hoeven F, Imgrund S, Kirsch J, Nickel W, Willecke K, Riezman H, Grone HJ, SandhoffR. 2011. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 21: 586-608.
9. Kihara A. 2012. Very long-chain fatty acids: elongation, physiology and related disorders. J. Biochem. 152:387-395.
10. Li W, SandhoffR, Kono M, Zerfas P, Hoffmann V, Ding BC, Proia RL, Deng CX. 2007. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int. J. Biol. Sci. 3:120-128.
11. Vasireddy V, Uchida Y, Salem N, Jr, Kim SY, Mandal MN, Reddy GB, Bodepudi R, Alderson NL, Brown JC, Hama H, Dlugosz A, Elias PM, Holleran WM, Ayyagari R. 2007. Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique ω-O-acylceramides in skin leading to neonatal death. Hum. Mol. Genet. 16:471-482.
12. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. 1991. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96:523-526.
13. Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R. 1993. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta 1182:147-151.
14. Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. 1994. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch. Dermatol. 130:452-456.
15. Di Nardo A, Wertz P, Giannetti A, Seidenari S. 1998. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm. Venereol. 78:27-30.
16. Bleck O, Abeck D, Ring J, Hoppe U, Vietzke JP, Wolber R, Brandt O, Schreiner V. 1999. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J. Invest. Dermatol. 113:894-900.
17. Janssens M, van Smeden J, Gooris GS, Bras W, Portale G, Caspers PJ, Vreeken RJ, Hankemeier T, Kezic S, Wolterbeek R, Lavrijsen AP, Bouwstra JA. 2012. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J. Lipid Res. 53:2755-2766.
18. Ohno Y, Suto S, Yamanaka M, Mizutani Y, Mitsutake S, Igarashi Y, Sassa T, Kihara A. 2010. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc. Natl. Acad. Sci. U. S. A. 107:18439-18444.
19. Adams DJ, Quail MA, Cox T, van der Weyden L, Gorick BD, Su Q, Chan WI, Davies R, Bonfield JK, Law F, Humphray S, Plumb B, Liu P, Rogers J, Bradley A. 2005. A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction. Genomics 86:753-758.
20. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG. 2001. A highly efficient Escherichia colibased chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65.
21. Matsumura H, Hasuwa H, Inoue N, Ikawa M, Okabe M. 2004. Lineagespecific cell disruption in living mice by Cre-mediated expression of diphtheria toxin A chain. Biochem. Biophys. Res. Commun. 321:275-279.
22. Hardman MJ, Sisi P, Banbury DN, Byrne C. 1998. Patterned acquisition of skin barrier function during development. Development 125:1541-1552.
23. Hauptmann G, Gerster T. 1994. Two-color whole-mount in situ hybridization to vertebrate and Drosophila embryos. Trends Genet. 10:266.
24. Caldelari R, Müller EJ. 2010. Short- and long-term cultivation of embryonic and neonatal murine keratinocytes. Methods Mol. Biol. 633:125-138.
25. SandhoffR. 2010. Very long chain sphingolipids: tissue expression, function and synthesis. FEBS Lett. 584:1907-1913.
26. Mizutani Y, Kihara A, Igarashi Y. 2005. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem. J. 390: 263-271.
27. Mizutani Y, Kihara A, Igarashi Y. 2006. LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with Wrelatively broad substrate specificity. Biochem. J. 398:531-538.
28. Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH, Jr, Futerman AH. 2008. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 283:5677-5684.
29. Mizutani Y, Kihara A, Chiba H, Tojo H, Igarashi Y. 2008. 2-Hydroxyceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J. Lipid Res. 49:2356-2364.
30. Ofman R, Dijkstra IM, van Roermund CW, Burger N, Turkenburg M, van Cruchten A, van Engen CE, Wanders RJ, Kemp S. 2010. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol. Med. 2:90-97.